Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30404 EPS, expectations were $-0.04. Operator ...

From cancer-resistant mole rats to 200-year-old whales, evolution has equipped long-lived species with unique biological ...

Aging brings about a range of changes—often unwelcome—to our bodies: sagging skin, graying or thinning hair, and a decline in muscle strength and ...

Eli Lilly stock jumps 18% in a month as strong Q3 results, upgraded guidance and rising demand for Mounjaro and Zepbound fuel ...

"Reaching places we assumed were protected." Scientists make concerning first-of-its-kind discovery while studying Amazon ...

Don't miss out on key current affairs updates for your Prelims and Mains preparation. Learn about Phool Waalon Ki Sair, the ...